Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7). [electronic resource]
Producer: 20160406Description: 521-9 p. digitalISSN:- 1699-3055
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- pathology
- Brain Neoplasms -- drug therapy
- Carboplatin -- administration & dosage
- Child
- Child, Preschool
- Cisplatin -- administration & dosage
- Cohort Studies
- Consolidation Chemotherapy -- methods
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Immunotherapy
- Induction Chemotherapy -- methods
- Infant
- Isotretinoin -- administration & dosage
- Male
- Neoadjuvant Therapy
- Neoplasm Staging
- Neuroblastoma -- drug therapy
- Neurosurgical Procedures
- Pilot Projects
- Prospective Studies
- Radiotherapy
- Thiotepa -- administration & dosage
- Topotecan -- administration & dosage
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.